BRIEF

on Cantourage Group SE (isin : DE000A3DSV01)

First Berlin Reiterates Buy Rating for Cantourage Group SE

First Berlin Equity Research GmbH has released an update on Cantourage Group SE, maintaining its "Buy" recommendation with a target price of €10.50. The focus of this update is Boots, a major UK pharmacy chain. Boots announced its entry into the UK's medical cannabis market with a nationwide online prescribing service. The entrance of a reputable name like Boots is expected to positively impact the acceptance of medical cannabis in Britain.

The potential market expansion could normalize cannabis as a treatment option, attracting more patients and facilitating regulatory changes in the future. This strategic move may have significant implications despite challenges like stigma. Cantourage's price target suggests a potential 126% upside, affirming confidence in the company's future prospects.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Cantourage Group SE news